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Adipocyte-speciﬁc Hypoxia-inducible gene 2
promotes fat deposition and diet-induced insulin
resistancew
Marina T. DiStefano 1,4, Rachel J. Roth Flach 1,5, Ozlem Senol-Cosar 1,6, Laura V. Danai 1,7,
Joseph V. Virbasius 1, Sarah M. Nicoloro 1, Juerg Straubhaar 1, Sezin Dagdeviren 2, Martin Wabitsch 3,
Olga T. Gupta 1,8, Jason K. Kim 2, Michael P. Czech 1,*
ABSTRACT
Objective: Adipose tissue relies on lipid droplet (LD) proteins in its role as a lipid-storing endocrine organ that controls whole body metabolism.
Hypoxia-inducible Gene 2 (Hig2) is a recently identiﬁed LD-associated protein in hepatocytes that promotes hepatic lipid storage, but its role in the
adipocyte had not been investigated. Here we tested the hypothesis that Hig2 localization to LDs in adipocytes promotes adipose tissue lipid
deposition and systemic glucose homeostasis.
Method: White and brown adipocyte-deﬁcient (Hig2ﬂ/ﬂ  Adiponection creþ) and selective brown/beige adipocyte-deﬁcient (Hig2ﬂ/ﬂ  Ucp1
creþ) mice were generated to investigate the role of Hig2 in adipose depots. Additionally, we used multiple housing temperatures to investigate
the role of active brown/beige adipocytes in this process.
Results: Hig2 localized to LDs in SGBS cells, a human adipocyte cell strain. Mice with adipocyte-speciﬁc Hig2 deﬁciency in all adipose depots
demonstrated reduced visceral adipose tissue weight and increased glucose tolerance. This metabolic effect could be attributed to brown/beige
adipocyte-speciﬁc Hig2 deﬁciency since Hig2ﬂ/ﬂ  Ucp1 creþ mice displayed the same phenotype. Furthermore, when adipocyte-deﬁcient Hig2
mice were moved to thermoneutral conditions in which non-shivering thermogenesis is deactivated, these improvements were abrogated and
glucose intolerance ensued. Adipocyte-speciﬁc Hig2 deﬁcient animals displayed no detectable changes in adipocyte lipolysis or energy
expenditure, suggesting that Hig2 may not mediate these metabolic effects by restraining lipolysis in adipocytes.
Conclusions: We conclude that Hig2 localizes to LDs in adipocytes, promoting adipose tissue lipid deposition and that its selective deﬁciency in
active brown/beige adipose tissue mediates improved glucose tolerance at 23 C. Reversal of this phenotype at thermoneutrality in the absence of
detectable changes in energy expenditure, adipose mass, or liver triglyceride suggests that Hig2 deﬁciency triggers a deleterious endocrine or
neuroendocrine pathway emanating from brown/beige fat cells.
 2016 The Author(s). Published by Elsevier GmbH. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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1. INTRODUCTION
Once considered an inert storage organ, adipose tissue is now known
to have numerous metabolic as well as endocrine functions with inputs
into whole body metabolism [1]. Adipose tissue contains adipocytes, or
fat cells, and preadipocytes, immune cells, and endothelial cells and
stores the majority of caloric energy in the form of neutral lipids in
adipocytes in organelles termed lipid droplets (LDs) [2,3]. LDs are
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highly dynamic organelles and are regulated by tissue-speciﬁc proteins
embedded in or associated with the droplet termed LD proteins. These
proteins can regulate LD size by inhibiting or facilitating lipolysis, the
breakdown of triglycerides (TGs) into glycerol and free fatty acids
(FFAs) [4]. LD proteins are relevant to human disease, as humans with
mutations in these proteins manifest lipodystrophy, fatty liver, and
metabolic syndrome [5].
Two main families of LD-associated proteins are the PAT family [6],
named for its three founding members Perilipin, Adipophilin, and Tip47
which have PAT domains, and the CIDE family [7]. The PAT family has
ﬁve members (Perilipin 1-5), while the CIDE family has three members
(Cidea, Cideb, and Cidec/Fsp27). LDs are heterogeneous in terms of
associated proteins and LD proteins generally demonstrate tissue-
speciﬁc distribution patterns [8]. Perilipins 1, 2, 3, and 4, Cidea, and
Fsp27 are expressed in adipose tissue and localize to LDs in adipo-
cytes [6,9]. In vitro and in vivo studies suggest that Perilipin 1 and
Fsp27 are two LD proteins that are critical for lipid storage in adipo-
cytes [10e14]. These observations in cells and animal models were
consistent with ﬁndings in lipodystrophic human subjects with Perilipin
1 and Fsp27 mutations [15,16].
In contrast to the major lipid storage function of white adipose tissue
(WAT), brown adipose tissue (BAT) generates heat through non-
shivering thermogenesis, or generation of heat by uncoupling of the
proton gradient of the electron transport chain from ATP synthesis,
mediated by uncoupling protein 1 (Ucp1) [17]. This differs from shiv-
ering thermogenesis, a temporary involuntary muscle movement that
generates heat [18]. Brown adipocytes are characterized by high
mitochondrial number, high Ucp1 expression, and small, numerous
(multilocular) LDs [3]. Until recently, BAT was thought to be present
solely for warmth in human infants and hibernating mammals, but
2FDG-PET scans have revealed that adult humans retain some func-
tional BAT that can expand in response to cold exposure [19e21]. As
BAT metabolism is energetically expensive, human BAT activation
presents a unique anti-obesity therapeutic potential. BAT thermogen-
esis can be activated by many means, but one of the most prominent
stimuli is increased beta-adrenergic activation in response to cold
temperatures [17]. For example, when rodents are housed at room
temperature (23 C), a mild cold stress, their metabolic rate can in-
crease up to 50% due to BAT energy consumption [22]. As housing
mice at room temperature (23 C) poses such a thermal stress, it can
be informative to subject mouse models to thermoneutrality (30 C for
mice), the temperature at which they are not subject to external cold
stress, to eliminate the contribution of nonshivering thermogenesis to
whole body metabolism [23].
Hypoxia-inducible gene 2 (Hig2) is a 63 amino acid protein that we
previously identiﬁed as a protein that localizes to LDs in hepatocytes
and promotes hepatic lipid deposition by inhibiting lipolysis [24]. In this
present study, we observed that Hig2 is highly expressed in the
adipocyte fraction of adipose tissue samples collected from bariatric
surgery patients, which in concert with its phenotype in hepatocytes
prompted us to examine its role in adipose tissue. We demonstrate that
Hig2 also localizes to LDs in adipocytes and its expression is increased
with both adipogenic differentiation and fat deposition in vitro, sug-
gesting that Hig2 may also play a role in adipose tissue in vivo. Mice
harboring an adipocyte-speciﬁc deletion of Hig2 demonstrate reduced
epididymal fat pad weight and improved glucose tolerance after high
fat diet (HFD). These effects are abrogated by thermoneutral housing,
suggesting that Hig2 may have an unexpected role in BAT in addition to
WAT function. In support of this hypothesis, mice harboring a brown
adipocyte-speciﬁc deletion of Hig2 also display improved glucose
tolerance. Interestingly, ex vivo glycerol release, serum glycerol, and
serum NEFAs are unchanged in adipocyte-speciﬁc Hig2-deﬁcient an-
imals compared with ﬂ/ﬂ controls, suggesting that Hig2 may use a
lipolysis-independent mechanism to promote lipid deposition in adi-
pocytes. Taken together, these results suggest that adipocyte-speciﬁc
Hig2 promotes adipocyte lipid deposition and glucose intolerance,
which may be entirely due to its control of BAT function in vivo.
2. MATERIALS AND METHODS
2.1. Animal studies
2.1.1. Breeding and genotyping
All of the studies performed were approved by the Institutional Animal
Care and Use Committee (IACUC) of the University of Massachusetts
Medical School. Animals were maintained in a 12 h light/dark cycle.
Hig2ﬂ/ﬂ animals were derived and genotyped as previously described
[24]. Hig2ﬂ/ﬂ animals were crossed to an Adiponectin creþ mouse line
(B6;FVB-Tg(Adipoq-cre)1Evdr/J, Jackson Laboratories). Hig2ﬂ/ﬂ ani-
mals were also crossed to a Ucp1 creþ mouse line (B6.FVB-Tg(Ucp1-
cre)1Evdr/J, Jackson Laboratories). Cre genotyping was performed
according to the method of Jackson Laboratories.
2.1.2. Diet and housing
At 4e6 weeks of age, male C57Bl/6J, Hig2ﬂ/ﬂ, Hig2ﬂ/ﬂ Adiponectin
creþ, or Hig2ﬂ/ﬂ Ucp1 creþ littermate animals were placed on a high
fat diet (60% fat, D12492i or 45% fat, D12451 (Figure 1 only), Research
Diets) or fed chow (Lab Diet 5P76) for 8,12,16 or 20 weeks. Animals
were switched to thermoneutral housing (30 C, 12 h light/dark cycle)
for 4 weeks and retained on the same diet they were previously fed.
2.1.3. Insulin and glucose tolerance tests
Mice were fasted 16 h for glucose tolerance tests and 4 h for insulin
tolerance tests. Mice were injected IP with 1 g/kg of glucose or 1 IU/kg
of insulin, blood was drawn from the tail vein at the indicated times,
and blood glucose levels were measured with a Breeze-2-glucose
meter (Bayer). Mice were euthanized by CO2 inhalation followed by
bilateral thoracotomy.
2.1.4. Metabolic cage studies
The metabolic cage studies were performed at the National Mouse
Metabolic Phenotyping Center (MMPC) at UMass. Mice were fed HFD
for 16 weeks and the metabolic cages were used to measure food
intake, RER, VO2 consumption, VCO2 production, energy expenditure,
fat and lean mass, and physical activity over a 3-day period, and an
average for each parameter was calculated (TSE Systems).
2.2. Ex vivo lipolysis
Mice were fasted for 16 h and euthanized by CO2 inhalation followed
by bilateral thoracotomy. Epididymal adipose tissue was removed and
cut into 80e100 mg pieces, placed in 0.5 ml Krebs-Ringer-Hepes
(KRH) Buffer pH 7.4, supplemented with 2.5% fatty acid-free BSA
and 1 mM sodium pyruvate. Samples were incubated in a 37 C
shaking water bath with or without 10 mM isoproterenol (Sigma, I5627)
for 2 h and glycerol release into KRH was measured using a calori-
metric assay (Sigma) according to the manufacturer’s instructions and
normalized to the fat pad weight.
2.3. Adipose tissue fractionation
Whole fat pads were isolated, minced, and placed in 5 ml Hanks
Balanced Salt Solution, pH 7.4, supplemented with 5% fatty acid-free
BSA and 1 mg/ml collagenase. Samples were incubated in a 37 C
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shaking water bath for 45 min, and the digestion reaction was
terminated with 5 ml of HBSS and BSA. Tissue was ﬁltered through a
200 mM ﬁlter, spun at 200 g for 5 min, and adipocyte and stromal
vascular fractions (SVF) were separated. Both were washed with HBSS
2 and then placed in TriPure for RNA isolation.
2.4. Plasma and lipid analysis
Mice were fasted for 16 h for plasma lipid analysis. Blood was taken
via cardiac puncture, and EDTA-containing plasma was collected. Total
serum cholesterol levels (ab65359 Abcam), serum triglyceride levels
(Triglyceride Determination Kit, Sigma), serum non-esteriﬁed fatty
Figure 1: Hig2 localizes to lipid droplets in human cultured adipocytes and its expression increases with adipogenesis and obesity. AeC, Adipose tissue was isolated
from patients undergoing bariatric surgery. A, microarray from omental adipose tissue. (#, p < 0.0001, n ¼ 6). B, C qRT-PCR was performed on indicated tissues for Hig2 and
normalized to Rplp0. B, fractionated omental adipose tissue. (*, p < 0.05, n ¼ 6e7). C, fractionated subcutaneous adipose tissue. (*, p < 0.05, n ¼ 7e8). Data are represented as
the mean  S.E. D, C57BL/6J animals were fed HFD for 20 weeks, eWAT and iWAT were isolated, RNA was extracted, and qRT-PCR was performed for Hig2 and normalized to
36B4. (***, p < 0.005, n ¼ 7e8). Data are represented as the mean  S.E. E, 3T3-L1 cells were differentiated, RNA was extracted on the indicated day, and qRT-PCR was
performed for Hig2 and normalized to 36B4. (n ¼ 3e7). Data are represented as the mean  S.E. F, SGBS cells were differentiated, RNA was extracted on the indicated day, and
qRT-PCR was performed for Hig2 and normalized to Rplp0. (*, p < 0.05, one-way analysis of variance, n ¼ 3e7). Data are represented as the mean  S.E. G, SGBS cells were
ﬁxed Day 10 post-differentiation. Cells were stained with Hig2 (red), Bodipy (green), and DAPI (blue). Left, merge of Hig2 and DAPI, right, merge of Hig2, Bodipy, and DAPI.
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acids (NEFAs) (Wako Diagnostics), and serum glycerol (Free Glycerol
Determination Kit, Sigma) were measured using calorimetric assays
according to the manufacturer’s instructions. Insulin and adiponectin
levels (Millipore) were measured by ELISA according to manufacturer’s
instructions.
2.5. Triglyceride and cholesterol extraction
Whole livers were isolated and ﬂash frozen in liquid nitrogen. Lipids
were extracted from livers via the Folch method [25]. Lipids were
dissolved in isopropanol with 1% Triton-X100. Triglyceride (Triglyc-
eride Determination Kit, Sigma) and cholesteryl ester (ab65359
Abcam) levels were measured using calorimetric assays according to
the manufacturer’s instructions and normalized to liver weight.
2.6. Human samples
Human adipose tissue samples were collected from morbidly obese
patients who underwent gastric bypass surgery between 2005 and
2009 at the University of Massachusetts Medical School [26]. Samples
used for microarray analysis were from BMI-matched female patients,
whereas qRT-PCR validations were performed in samples from both
males and females. Adipose tissue samples were obtained from lower
abdominal wall (for subcutaneous) and omentum (for visceral) during
the surgery. Informed consent was given by the patients and the study
was approved by University of Massachusetts Medical School Insti-
tutional Review Board. Microarray data have been deposited in GEO
database under accession code GSE20950.
2.7. RNA isolation and RT-qPCR
Total RNA was isolated from cells or tissues using TriPure isolation re-
agent (Roche) according to the manufacturer’s protocol. The isolated RNA
was DNase treated (DNA-free, Life Technologies), and cDNA was syn-
thesized using iScript cDNA synthesis kit (BioRad). RT-qPCR was per-
formed on the BioRad CFX96 using iQ SybrGreen supermix and 36B4
served as the reference gene. Primer sequences are as follows: 36B4 (50-
TCCAGGCTTTGGGCATCA-30, 50-CTTTATCAGCTGCACATCACTCAGA-30);
Hig2 (50-CATGTTGACCCTGCTTTCCAT-30, 50-GCTCTCCAG-
TAAGCCTCCCA-30); Human Primers: RPLP0 (50-CAGATTGGCTACC-
CAACTGTT-30, 50-GGGAAGGTGTAATCCGTCTCC-30); HIG2 (50-
AAGCATGTGTTGAACCTCTACC-30, 50-GATGGAGAGTAGGGTCAGTACC-30).
2.8. Cell culture
3T3-L1 ﬁbroblasts were grown and differentiated into adipocytes as
previously described [27]. Simpson-Golabi-Behmel syndrome (SGBS)
cells were obtained from Dr. Martin Wabitsch’s laboratory. SGBS ﬁ-
broblasts were grown and differentiated into adipocytes as previously
described with modiﬁcations [28]. Brieﬂy, SGBS ﬁbroblasts were
grown to conﬂuence in DMEM/F12 containing 10% fetal bovine serum,
33 mM biotin, 17 mM pantothenic acid, 50units/ml penicillin, and
50 mg/ml streptomycin. Two days after conﬂuence, serum-free dif-
ferentiation medium (25 nM dexamethasone, 250 mM 1-methyl-3-
isobutylxanthine, 0.01 mg/ml transferrin, 0.2 nM triiodothyronine,
20 nM human insulin, 2 mM rosiglitazone, and 100 nM cortisol) was
added. Four days later, the differentiation cocktail was replaced with
maintenance medium (DMEM/F12, biotin, pantothenic acid, trans-
ferrin, insulin and cortisol). Cells were considered fully mature 14 days
post-differentiation.
2.9. Cell imaging
Cells were ﬁxed in 10% buffered formalin in PBS for 1 h, blocked in 1%
normal goat serum in PBS for 1 h at room temperature, incubated with
Hig2 antibodies (1:100, Rockland Immunochemicals [24]) for 2 h at
room temperature, incubated with ﬂuorescent secondary antibodies
1:1000 for 1 h, treated with Bodipy 493/503 (ThermoFisher, D-3922)
at 1:10,000 for 15 min, and mounted with Prolong Gold with DAPI (Life
Technologies). Cells were imaged at room temperature with a Sol-
amere Technology Group modiﬁed Yokogawa CSU10 Spinning Disk
Confocal with a Nikon TE-2000E2 inverted microscope at 60.
2.10. Histology
Tissues were isolated and ﬁxed in 10% formalin, embedded in parafﬁn,
sectioned, and stained with hematoxylin and eosin (H&E). The UMass
Morphology Core performed the embedding, sectioning, and staining.
2.11. Statistical analysis
Data were analyzed in GraphPad Prism 6 (GraphPad Software, Inc.). A
two-tailed student’s t test with Welch’s Correction was used to
compare two groups of data. Where indicated, data were analyzed
using a one-way ANOVA or a two-way ANOVA with repeated measures.
P < 0.05 was considered to be signiﬁcant. The Grubb’s test was used
to determine if there were statistical outliers and if an outlier was
determined, it was removed from the statistical analysis. Variance was
estimated using standard error of the mean.
3. RESULTS
3.1. Hig2 localizes to lipid droplets in human cultured adipocytes
and its expression increases with adipogenesis and obesity
As part of an effort to identify genes associated with obesity and insulin
resistance, we performed microarray gene expression analyses on
omental adipose tissue from human patients undergoing bariatric
surgery after fractionation into adipocytes and stromal vascular fraction
(SVF) [26] and sorted genes by adipocyte speciﬁcity. One of the top
gene hits that displayed 10-fold enrichment in signal in the adipocyte
fraction compared with SVF was Hig2 (Figure 1A). To validate this
result, we performed qRT-PCR and Hig2 expression was 28-fold higher
in human omental adipocytes (Figure 1B) and 12-fold higher in human
subcutaneous adipocytes (Figure 1C) compared with the respective
SVFs. We demonstrated previously that Hig2 expression increased with
lipid deposition in mouse liver [24]. To investigate whether this was
also the case in adipose tissue, we placed wild type mice on a HFD for
20 weeks, and measured Hig2 expression in epididymal white adipose
tissue (eWAT) and inguinal WAT (iWAT) by qRT-PCR. Although it was
unchanged in iWAT, Hig2 expression in eWAT of wild type animals
doubled with high-fat-feeding (Figure 1D).
As LD proteins often display increases in expression with adipogenic
differentiation [29e33], we also measured Hig2 expression by qRT-
PCR in an adipocyte cell line and an adipocyte cell strain upon adi-
pogenic stimulation. In the murine 3T3-L1 adipocyte cell line, Hig2
expression was unchanged with differentiation (Figure 1E); however,
its expression was increased by 10-fold after 14 days of adipogenic
differentiation in the human Simpson-Golabi-Behmel syndrome (SGBS)
adipocyte cell strain (Figure 1F). We veriﬁed this result by assessing
endogenous Hig2 protein expression in SGBS cells on day 10, post-
differentiation by immunoﬂuorescence. Interestingly, Hig2 (red) local-
ized to Bodipy-positive (green) LDs, as previously observed in primary
hepatocytes [24], demonstrating that Hig2 is also a LD protein in
human adipocytes (Figure 1G).
3.2. Adipocyte-speciﬁc Hig2 deﬁcient animals display improved
glucose homeostasis when BAT is active
To further investigate the role of adipocyte-speciﬁc Hig2, mice with
adipocyte-speciﬁc Hig2 deﬁciency (Hig2AdKO) were generated by
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Figure 2: Adipocyte-speciﬁc Hig2 deﬁcient animals display improved glucose homeostasis when BAT is active. A, schematic of adiponectin-cre-mediated Hig2 deletion.
BeD, indicated tissues were isolated from ﬂ/ﬂ and Hig2AdKO mice, RNA was extracted, and qRT-PCR was performed for Hig2 and normalized to 36B4. B, isolated epididymal and
inguinal adipocytes. (*, p ¼ 0.05, n ¼ 3e9). C, brown adipose tissue. (*, p < 0.05, n ¼ 5e8). D, kidney and spleen. (**, p < 0.01, n ¼ 4e10). Data are represented as the
mean  S.E. E,F,I, ﬂ/ﬂ or Hig2AdKO animals were fed ND or HFD at 23 C for 16 weeks. G,H,J, ﬂ/ﬂ or Hig2AdKO animals were fed ND or HFD for 8 weeks, then moved to 30 C for
4 weeks. E, body weight curves at 23 C. (n ¼ 8e20). F, insulin tolerance test at 23 C. (n ¼ 4e13). G, body weight curves at 30 C. (n¼ 3e9). H, insulin tolerance test at 30 C.
(n ¼ 3e5). I, glucose tolerance test at 23 C. (*, p < 0.05, **, p < 0.01, ***, p < 0.001, $, p < 0.005, two-way analysis of variance, n ¼ 5e13). J, glucose tolerance test at
30 C. (*, p < 0.05, $, p < 0.05, two-way analysis of variance, n ¼ 3e10). Data are represented as the mean  S.E.
MOLECULARMETABOLISM 5 (2016) 1149e1161  2016 The Author(s). Published by Elsevier GmbH. This is an open access article under the CCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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crossing Hig2ﬂ/ﬂ mice with Adiponectin creþ mice (Figure 2A). To
determine whether the deletion was adipocyte-speciﬁc, we isolated
adipocytes from eWAT and iWAT and performed qRT-PCR for Hig2. As
expected, there was a signiﬁcant 60% reduction in Hig2 mRNA
expression in eWAT and 70% reduction in iWAT in Hig2AdKO animals
compared with ﬂ/ﬂ littermate controls (Figure 2B). There was also a
signiﬁcant 50% reduction in Hig2 expression in whole BAT but no
change in non-adipose tissues such as kidney and spleen, demon-
strating that the deletion is speciﬁc to adipocytes (Figure 2C,D).
Mice are typically housed at 23 C, which presents a cold stress and
persistent activation of thermogenic pathways. Cold stress increases
catecholamine levels, thereby activating nonshivering thermogenesis
in BAT and substantially increasing food intake and metabolic rate [22].
Thus, it has been informative to characterize mouse models with
genetic alterations in energy storage at room temperature (23 C)
versus thermoneutrality (30 C), a temperature that poses no thermal
stress and little BAT activation [23,34,35]. Recently, it has been
demonstrated that housing mice with LD protein deﬁciencies at ther-
moneutrality reveals phenotypes that more closely resemble lip-
odystrophic syndromes in humans with mutations in LD protein genes
[36]. For these reasons, Hig2AdKO animals were fed chow or HFD for
16 weeks at 23 C and maintained at the same temperature, or fed
chow or HFD for 16 weeks at 23 C then moved to 30 C for four
weeks, and metabolic parameters were assessed.
There were no signiﬁcant differences in body weight (fat or lean mass),
or insulin sensitivity as measured by an insulin tolerance test (ITT),
Figure 3: Adipocyte-speciﬁc Hig2 deﬁciency alters adipose tissue distribution in HFD-fed mice at 23 C. AeH, ﬂ/ﬂ or Hig2AdKO animals were fed ND or HFD for 16 weeks.
AeD, Tissues were weighed and normalized to body weight. A, eWAT. (**, p < 0.01, n ¼ 5e13). B, iWAT. (n ¼ 5e14). C, liver. (n ¼ 5e10). D, BAT. (**, p < 0.01, n ¼ 5e12).
Data are represented as individual values  S.E. EeH, HFD tissues were sectioned and stained with H&E. E, eWAT. F, iWAT. G, liver. H, BAT.
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energy expenditure, or respiratory exchange rate (RER) between ge-
notypes in either feeding condition at 23 C (Figure 2E,F,
Supplementary Figure 1) or 30 C (Figure 2G,H), but Hig2AdKO animals
had signiﬁcantly improved glucose tolerance compared with ﬂ/ﬂ lit-
termates in the high-fat-fed condition as measured by a glucose
tolerance test (GTT) at 23 C (Figure 2I), suggesting that adipocyte Hig2
promotes glucose intolerance in diet-induced obesity. Although insulin
levels are signiﬁcantly increased in Hig2AdKO animals after 16 weeks
high-fat feeding (Supplementary Table 1), they are likely not the cause
of the improved glucose tolerance in these animals, as glucose
tolerance is also improved in Hig2AdKO animals fed HFD for 8 weeks, a
time point when insulin levels are unchanged (Supplementary
Figure 2). In contrast, HFD-fed Hig2AdKO animals surprisingly had a
signiﬁcantly worsened glucose intolerance compared with ﬂ/ﬂ controls
after four weeks of housing at thermoneutral temperature (Figure 2J).
This represented a marked reversal in the metabolic consequences of
Hig2 deﬁciency that was dependent on housing temperature, which is
similar to the phenotype of Fsp27-deﬁcient animals [36].
3.3. Adipocyte-speciﬁc Hig2 deﬁciency alters adipose tissue
distribution in HFD-fed mice at 23 C
LD protein deﬁciencies alter lipid deposition in vivo [10,11,37e40].
Thus, we examined fat pad and liver weights of ﬂ/ﬂ and Hig2AdKO
animals at 23 C. In chow-fed mice, eWAT and iWAT fat pad weights
were unchanged between genotypes (Figure 3A,B). However, upon
HFD-feeding, Hig2AdKO animals had signiﬁcantly reduced eWAT
Figure 4: Thermoneutrality abrogates the altered fat distribution in Adipocyte-speciﬁc Hig2-deﬁcient mice. AeH, ﬂ/ﬂ or Hig2AdKO animals were fed ND or HFD for 8
weeks, then moved to 30 C for 4 weeks. AeD, Tissues were weighed and normalized to body weight. A, eWAT. (n ¼ 3e10). B, liver. (n ¼ 3e10). C, BAT. (n ¼ 3e10). D, iWAT.
(n ¼ 3e10). Data are represented as individual values  S.E. EeH, the indicated tissues were sectioned and stained with H&E. E, eWAT. F, liver. G, BAT. H, iWAT.
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weight compared with ﬂ/ﬂ controls (3.9 0.4% vs 5.7 0.2%), while
iWAT weight was unchanged (Figure 3A,B). This reduction corre-
sponded to a concomitant increase in liver weight from 2.7 0.07% of
body weight in controls to 3.1  0.11% in Hig2AdKO animals
(Figure 3C). Chow-fed Hig2AdKO animals also had signiﬁcantly
increased liver weight compared with ﬂ/ﬂ littermates (Figure 3C).
The reduction in eWAT weight suggests that Hig2 deﬁciency reduces
depot-speciﬁc fat deposition. Thus, H&E-stained histology from HFD
animals was examined to determine whether there were visible al-
terations in AT and liver to complement the weight differences. While
eWAT, iWAT, and liver histology appeared unchanged between the
genotypes (Figure 3E,F,G), there was a striking visible reduction in
lipids in BAT of Hig2AdKO animals compared with ﬂ/ﬂ controls
(Figure 3H). There were no differences in BAT weight between ge-
notypes in the ND or HFD-fed mice (Figure 3D). Taken together, these
results suggest that adipocyte-speciﬁc Hig2 deﬁciency alters adipose
tissue distribution in obesity.
3.4. Thermoneutrality abrogates the altered fat distribution in
adipocyte-speciﬁc Hig2-deﬁcient mice
As glucose intolerance on HFD was worsened with thermoneutral
housing, we also assessed alterations in fat distribution in the
Hig2AdKO animals at 30 C. Indeed, the reduction in eWAT weight that
was observed in Hig2AdKO animals at 23 C was abrogated when the
animals were placed at thermoneutrality (Figure 4A). Furthermore, the
increase in liver weight that was observed in Hig2AdKO animals at
23 C was also suppressed (Figure 4B); however, there continued to
be no difference in iWAT or BAT weight between genotypes
(Figure 4C,D). Additionally, H&E-stained histology sections of eWAT,
iWAT, BAT, and liver were examined and no visual differences were
observed between ﬂ/ﬂ and Hig2AdKO animals (Figure 4EeH). This was
in striking contrast from 23 C, at which temperature the Hig2AdKO
mouse BAT was cleared of lipids (Figure 3H). Thus, all phenotypic
differences in ﬂ/ﬂ vs. Hig2AdKO mice were abrogated at thermoneu-
trality (glucose tolerance, eWAT weight, liver weight, BAT lipid con-
tent), which suggests that these parameters may be mediated by BAT
function that is dependent on activation of BAT by cold stress.
3.5. Adipocyte-speciﬁc Hig2 deﬁciency does not alter ex vivo
glycerol release
We have previously demonstrated that Hig2 deﬁciency increased
lipolysis in hepatocytes [24], and thus investigated the role of Hig2
deﬁciency in controlling these parameters in adipocytes. We measured
ex vivo glycerol release from eWAT explants of ﬂ/ﬂ and Hig2AdKO
animals in basal and isoproterenol-stimulated conditions, and found no
difference between genotypes at 23 C (Figure 5A) or 30 C
(Figure 5B). Serum non-esteriﬁed fatty acids (NEFAs) and serum
glycerol, two systemic measures of lipolysis, were also found to be
unchanged between genotypes at 23 C (Supplementary Table 1) and
30 C (Supplementary Table 2).
3.6. Brown adipocyte-speciﬁc Hig2 deﬁciency is sufﬁcient to
improve glucose tolerance at 23 C
Thermoneutrality abrogated the improvement in glucose tolerance
mediated by adipocyte-speciﬁc Hig2 deﬁciency and thermoneutrality
reduces both lipolysis and brown fat activity [41]. We crossed Hig2ﬂ/ﬂ
animals with brown and beige/brite adipocyte-speciﬁc Ucp1
creþ animals to generate brown adipocyte-speciﬁc Hig2 knockout
animals (Hig2BATKO) and elucidate the role of Hig2 speciﬁcally in the
brown adipocyte (Figure 6A). Tissues from ﬂ/ﬂ and Hig2BATKO animals
were excised to assess deletion speciﬁcity. There was a signiﬁcant
reduction in Hig2 mRNA in whole BAT as measured by qRT-PCR
(Figure 6B), but no reduction in other tissues including white adipo-
cytes, spleen, or kidney (Figure 6C,D), demonstrating that the deletion
is speciﬁc. Interestingly, Hig2 expression was upregulated by
approximately 7-fold in eWAT adipocytes of Hig2BATKO animals
compared with ﬂoxed controls (Figure 6C).
To evaluate the role of brown adipocyte-speciﬁc Hig2 deﬁciency on
whole body metabolism, ﬂ/ﬂ and Hig2BATKO animals were placed
on chow or HFD for 8 weeks at 23 C or placed on HFD for
4 weeks at 23 C and moved to 30 C for four weeks and metabolic
parameters were assessed. There were no differences in body
weight or insulin sensitivity between the genotypes at 23 C
(Figure 6E,F) or 30 C (Figure 6G,H). However, when challenged with
a GTT, HFD-fed Hig2BATKO animals at 23 C were signiﬁcantly more
glucose tolerant compared to their ﬂ/ﬂ control littermates (Figure 6I),
similar to the Hig2AdKO animals (Figure 2I). Furthermore, this
improvement in glucose tolerance in the Hig2BATKO animals was
abrogated by thermoneutral housing (Figure 6J), similar to the
Hig2AdKO animals (Figure 2J). The loss of improved glucose toler-
ance at thermoneutrality in both animal models suggests that Hig2
deletion in active brown fat mediates the observed improvements in
glucose tolerance.
3.7. Brown adipocyte-speciﬁc Hig2 deﬁciency does not alter
adipose tissue distribution at 23 C
To determine whether Hig2 deﬁciency in brown adipocytes was
responsible for the reduced eWAT weight and increased liver weight in
Figure 5: Adipocyte-speciﬁc Hig2 deﬁciency does not alter ex vivo glycerol release. A, ﬂ/ﬂ or Hig2AdKO animals were fed ND or HFD for 16 weeks at 23 C. A, ex vivo
lipolysis of eWAT. (*, p < 0.05, **, p < 0.01, ***p < 0.005, n ¼ 3e5). Data are represented as the mean  S.E. B, ﬂ/ﬂ or Hig2AdKO animals were fed ND or HFD for 8 weeks at
23 C and then moved to 30 C for 4 weeks. B, ex vivo lipolysis of eWAT. (***, p < 0.005, n ¼ 3e10). Data are represented as the mean  S.E.
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Figure 6: Brown adipocyte-speciﬁc Hig2 deﬁciency is sufﬁcient to improve glucose tolerance at 23 C. A, schematic of Ucp1-cre-mediated Hig2 deletion. BeD, indicated tissues
were isolated from ﬂ/ﬂ and Hig2BATKOmice, RNAwas extracted, and qRT-PCRwas performed for Hig2 and normalized to 36B4. B, brown adipose tissue. (#, p< 0.001, n¼ 7). C, isolated
inguinal (iWAT) and epididymal (eWAT) adipocytes. (**, p< 0.01, n¼ 3e7). D, kidney and spleen. (n¼ 3e8). Data are represented as the mean S.E. E,F,I, ﬂ/ﬂ or Hig2BATKO animals
were fed ND or HFD at 23 C for 8 weeks. G,H,J, ﬂ/ﬂ or Hig2BATKO animals were fed ND or HFD for 4 weeks, thenmoved to 30 C for 4 weeks. E, body weight curves at 23 C. (n¼ 5e10).
F, insulin tolerance test at 23 C. (n¼ 3e10). G, body weight curves at 30 C. (n¼ 8). H, insulin tolerance test at 30 C. (n¼ 3e8). I, glucose tolerance test at 23 C. (*, p< 0.05, **,
p < .01, $, p < 0.05, two-way analysis of variance, n ¼ 5e13). J, glucose tolerance test at 30 C. (n ¼ 5e11). Data are represented as the mean  S.E.
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Hig2AdKO animals, liver and fat pads from ﬂ/ﬂ and Hig2BATKO animals
after 8 weeks of HFD at 23 C were weighed. It was observed that eWAT,
iWAT, BAT and liver weights were unchanged between genotypes
(Figure 7AeD), in contrast to the phenotype observed in the animals
lacking Hig2 in all adipose depots. In accordance with these results, H&E-
stained histological sections of eWAT, iWAT, BAT, and liver appeared to be
unchanged between Hig2BATKO animals and ﬂ/ﬂ controls (Figure 7EeH).
Taken together, these results demonstrate that brown adipocyte-speciﬁc
Hig2 deﬁciency alone is not sufﬁcient to redistribute fat deposition in WAT
as observed in the Hig2AdKO animals.
3.8. Brown adipocyte-speciﬁc Hig2 deﬁciency does not alter
ex vivo glycerol release
We also measured glycerol release into media of eWAT explants from
Hig2BATKO and ﬂ/ﬂ controls and did not observe any differences
between genotypes in mice housed at 23 C (Figure 8A) or at ther-
moneutrality (Figure 8B), similar to the results observed from
adipocyte-speciﬁc Hig2 deﬁcient mice suggesting that both brown and
white adipose tissue Hig2 is not required for inhibition of adipose tissue
lipolysis and glycerol release. Additionally, serum NEFAs and glycerol,
both measures of lipolysis, were also unchanged at 23 C
Figure 7: Brown adipocyte-speciﬁc Hig2 deﬁciency does not alter adipose tissue distribution at 23 C. AeH, ﬂ/ﬂ or Hig2BATKO animals were fed HFD for 8 weeks. AeD,
Tissues were weighed and normalized to body weight. A, eWAT. (n ¼ 8e10). B, iWAT. (n ¼ 8e10). C, BAT. (n ¼ 8e10). D, liver. (n ¼ 8e10). Data are represented as individual
values  S.E. EeH, the indicated tissues were sectioned and stained with H&E. E, eWAT. F, iWAT. G, BAT. H, Liver.
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(Supplementary Table 3) and 30 C (Supplementary Table 4). Taken
together, these data suggest that Hig2 localizes to LDs in human
adipocytes without regulating lipolytic processes, but instead has a
surprising function to promote glucose intolerance in mice.
4. DISCUSSION
Adipose tissue is a critical metabolic organ and BAT and WAT display
distinct metabolic functions. While WAT functions in energy storage,
active BAT promotes energy consumption. Their functions and phys-
iology suggest that LDs and LD proteins may differ between tissues. As
such, recent studies have suggested that LD proteins such as Fsp27
can have tissue-speciﬁc roles, and that their physiological functions
vary depending on environmental conditions, which can alter BAT
activity [36]. In this study, we demonstrate that Hig2 also has tissue-
speciﬁc roles and has varying physiological function in different
environmental conditions.
Hig2 deﬁciency in adipocytes (Figure 2) reduced eWAT mass, largely
cleared BAT of lipids, and improved HFD-mediated glucose intolerance
in vivo (Figures 2I and 3A,H). Interestingly, these improvements were
abrogated when the animals were placed at thermoneutrality for 4
weeks (Figures 2J and 4A,G), suggesting that BAT activity or other
physiological responses to cold stress mediated these effects. To test
that hypothesis, ex vivo glycerol release was measured in eWAT from
animals housed at room temperature and thermoneutrality and was
unchanged between the genotypes (Figure 5A,B). Serum NEFAs and
serum glycerol, two systemic measures of lipolysis, were also un-
changed (Supplementary Tables 1 and 2). These data suggest that
Hig2 could be promoting lipid deposition in adipocytes by a different
mechanism than lipolytic inhibition, although the exact mechanism is
currently unclear. Recent data suggest that lipolytic regulation in ad-
ipose tissue and liver may differ. Cgi-58 physically interacts with Atgl
and promotes lipolysis in adipocytes [42]. However, it has recently
been demonstrated that Cgi-58 regulates hepatic lipid storage both in
the presence and in the absence of Atgl, suggesting that their physical
interaction may not be necessary to promote lipolysis in hepatocytes
[43]. Additionally, Perilipin 1 is present in adipocytes, but absent in
hepatocytes, where Perilipins 2/3 are tissue-speciﬁc PAT proteins and
Perilipins 2/3 do not inhibit lipolysis as efﬁciently as Perilipin 1 [6,11].
Further work will need to be done to pinpoint the tissue-speciﬁc dif-
ferences in lipolytic signaling.
To examine the role of brown-adipocyte-speciﬁc Hig2, Hig2BATKO
animals were generated and metabolically characterized. These
animals displayed no improvements in serum parameters, histology,
or adipose tissue distribution, but had signiﬁcantly improved glucose
tolerance which was abrogated by thermoneutral housing, sug-
gesting that brown adipocytes alone have little role to regulate the
altered lipid deposition in eWAT or clearing of BAT lipids in Hig2AdKO
animals, but play a signiﬁcant role in the metabolic improvements
that were observed (Supplementary Tables 3 and 4, Figures 6, 7).
The mechanism whereby brown adipocyte-speciﬁc Hig2-deﬁciency
prevents obesity-mediated glucose intolerance is currently unclear.
Ex vivo glycerol release, serum NEFAs, and serum glycerol were
unchanged between genotypes, suggesting that brown adipocyte-
speciﬁc Hig2 deﬁciency does not alter lipolysis (Figure 8,
Supplementary Tables 3 and 4) Unchanged food intake, oxygen
consumption, energy expenditure, and RER in the Hig2AdKO animals
(Supplementary Figure 1) suggest that improvements may be
mediated independent of BAT thermogenesis. One possibility points
to the putative endocrine function of BAT. Recent experiments
suggest that, in addition to its thermogenic properties, activated BAT
may function as an endocrine organ and can secrete beneﬁcial
molecules that improve overall metabolic health [44e48]. For
instance, transplanting BAT into WAT of diabetic mice promoted
adipogenesis and restored euglycemia [49]. Conﬂicting data suggest
that although Hig2 may have an N-terminal signal sequence [50], it
may be not be secreted [51], thus, future work is needed to inves-
tigate Hig2 as a putative factor secreted factor.
Metabolic characterization of the Hig2BATKO animals suggests that
brown adipocyte-speciﬁc deﬁciency of Hig2 is not sufﬁcient to alter fat
distribution of WAT, but improves HFD-mediated glucose intolerance
(Figures 6, 7). Future experiments targeting Hig2 speciﬁcally in white
adipocytes would be useful to determine its true contribution to the
phenotype of Hig2AdKO animals. Thermoneutrality experiments, which
more accurately represent human living conditions, demonstrate that
adipocyte-speciﬁc Hig2 deletion is detrimental to metabolic health
(Figures 2 and 4). As Hig2 is localized to LDs in human adipocytes and
is highly expressed in adipocytes of human subjects (Figure 1), it will
be interesting to investigate whether there are rare human mutations in
Hig2, much like the canonical LD proteins Perilipin 1, and Fsp27/Cidec
[15,16,52], and if these mutations cause partial lipodystrophy and
metabolic dysregulation. Future experiments to challenge the
Hig2AdKO animals with cold exposure to evaluate glucose tolerance
would be insightful due to hyper-activation of lipolysis and BAT at these
temperatures [41]. Here, we have demonstrated that Hig2 expression
promotes lipid deposition and diet-induced glucose intolerance in
adipose tissue and liver [24]. Thus, it will be of interest to investigate
the role of Hig2 in other tissues. LDs are relevant in a large variety of
cells; thus, the role of Hig2 in lipid deposition in other tissues is still
largely unanswered and is an active area of investigation.
Figure 8: Brown adipocyte-speciﬁc Hig2 deﬁciency does not alter ex vivo glycerol release. A, ﬂ/ﬂ or Hig2BATKO animals were fed HFD for 8 weeks at 23 C. A, ex vivo
lipolysis of eWAT. (*, p < 0.05, **, p < 0.01, ***, p < 0.005 n ¼ 3e8). Data are represented as the mean  S.E. B, ﬂ/ﬂ or Hig2BATKO animals were fed HFD for 4 weeks at 23 C
and then moved to 30 C for 4 weeks. B, ex vivo lipolysis of eWAT (**, p < 0.01 n ¼ 3e6). Data are represented at the mean  S.E.
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